Giacomo Tognini, Forbes Staff

Author's posts

Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus

A decade ago, Timothy Springer made an investment on a fledgling biotech company. Now he talks about that bet and other investments.

Can The U.S. Learn From Italy, Where Antibody Test Makers Are Fighting For A New Market?

In a bid to reopen their economies, Italy’s 20 regions are buying hundreds of thousands of antibody tests. Amid the chaos, the world’s top test makers are battling it out for control of a new, poorly regulated market — and the U.S. could soon find itse…

Inside The Tiny Italian Biotech Startup Racing To Develop A Coronavirus Vaccine

Takis Biotech, a small biotech outfit with only 25 employees based outside Rome, is hard at work on several candidates for a COVID-19 vaccine.